E. coli

An artists depiction of E coli one of the many bacteria that is becoming resistant to first-line antibiotics The bacteria
Biotech

Sanofi takes $250M hit after J&J E. coli vaccine fails in ph. 3

A year and a half after Sanofi swooped on Johnson & Johnson’s dismantled vaccines unit to pick up an E. coli candidate, the asset failed its trial.
James Waldron Feb 13, 2025 4:14am
An artists depiction of E coli one of the many bacteria that is becoming resistant to first-line antibiotics The bacteria

Sanofi pays $175M for J&J's late-phase E. coli vaccine

Oct 3, 2023 7:32am
bacteria

Engineered native gut bacteria show promise in diabetes

Aug 5, 2022 9:51am